The version of Internet Explorer that you are using is no longer supported by Microsoft. Information may not appear correctly. Please update your browser.

  • A
  • A
  • A
  • (resize font)

Research & Development

LSVT Global, Inc. has an active research and development focus. Our goal is to continue to improve the quality of our therapy protocols and training products.

Our R&D efforts are supported by internal funding as well as external funds from various granting organizations.

Grants:  LSVT Global has received several Small Business Innovation Research (SBIR) grants from the National Institutes of Health, National Institute on Deafness and Other Communication Disorders and the a training development grant from the Davis Phinney Foundation for Parkinson disease.  These grants have helped increase accessibility for speech clinicians to be trained and certified in LSVT LOUD and advanced our LSVT Companion System for LSVT LOUD. 

  • NIH
  • SBIR R43 R43 DC-007241 (Fox and Ramig). Increased access to training in efficacious speech therapy through technology
  • SBIR R43 DC-010498 (Fox and Ramig). Telehealth delivery of software-enhanced speech therapy for Parkinson Disease.
  • SBIR R43 DC-010956  (Fox and Ramig). Independent delivery of software-enhanced speech therapy for Parkinson disease.
  • Davis Phinney Foundation for Parkinson disease.

Patents and Trademarks
LSVT Intellectual Property - Our products are both patent and copyright protected within North America and internationally and the LSVT® trademark and other logos appearing within LSVT Global’s website are registered and unregistered trademarks of LSVT Global, Inc.

Regulatory Affairs:
The LSVT Companion® System has been cleared for marketing by the Food and Drug Administration in the US (Clearance (510K)) as well as clearance in the European Union, Australia, China, New Zealand and Canada.